Top compounds associated with response to AC003002.6


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.18 0.0001
mRNA pac-1 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA prima-1 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA barasertib CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
Download CSV